Company / Current Liabilities per Share
Corbus Pharmaceuticals Holdings, Inc. Current Liabilities per Share History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$3.03
FY2022
5-year range
$0.17 / $3.03
FY2018-FY2022
Trend
+1662.0%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share changed +1662% YoY in FY2022, a notable deviation from the 7-year average annual change of +254%.
Based on SEC 10-K filings.
3.03 in FY2022 with a 5-year CAGR of +69.3%.
Increased from $0.49 to $3.03 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +70.7%
- 5-Year CAGR
- +69.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, current liabilities per share increased 1662.0% year-over-year.
- Lowest current liabilities per share in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -12.48 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $3.03 | +1662.0% |
| FY2021 | $0.17 | -65.1% |
| FY2020 | $0.49 | -19.1% |
| FY2019 | $0.61 | +87.3% |
| FY2018 | $0.33 | +49.1% |
| FY2017 | $0.22 | -7.8% |
| FY2016 | $0.24 | +69.1% |
| FY2015 | $0.14 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026